Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring

Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.” | Two and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”

Raccontata dafiercepharma.com